News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,823 Results
Type
Article (14911)
Company Profile (300)
Press Release (266606)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (79899)
Career Advice (162)
Deals (13350)
Drug Delivery (39)
Drug Development (50718)
Employer Resources (31)
FDA (5842)
Job Trends (5169)
News (145180)
Policy (10081)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (920)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21778)
ALS (124)
Alzheimer's disease (1031)
Antibody-drug conjugate (ADC) (241)
Approvals (6035)
Artificial intelligence (258)
Autoimmune disease (110)
Automation (9)
Bankruptcy (105)
Best Places to Work (4562)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (344)
Cancer (3129)
Cardiovascular disease (237)
Career advice (147)
Career pathing (7)
CAR-T (217)
CDC (5)
Cell therapy (563)
Cervical cancer (14)
Clinical research (43685)
Collaboration (1151)
Company closure (2)
Compensation (592)
Complete response letters (39)
COVID-19 (1100)
CRISPR (86)
C-suite (550)
Cystic fibrosis (112)
Data (4320)
Denatured (15)
Depression (92)
Diabetes (255)
Diagnostics (1380)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (187)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (31658)
Editorial (26)
Employer branding (4)
Employer resources (29)
Events (51693)
Executive appointments (621)
FDA (7590)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (980)
Gene editing (182)
Generative AI (21)
Gene therapy (486)
GLP-1 (504)
Government (1149)
Grass and pollen (3)
Guidances (166)
Healthcare (6614)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (39)
Indications (66)
Infectious disease (1204)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (18)
IPO (7349)
IRA (12)
Job creations (867)
Job search strategy (129)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1400)
Liver cancer (41)
Longevity (11)
Lung cancer (419)
Lymphoma (248)
Machine learning (24)
Management (7)
Manufacturing (375)
MASH (130)
Medical device (2671)
Medtech (2680)
Mergers & acquisitions (6627)
Metabolic disorders (725)
Multiple sclerosis (105)
NASH (13)
Neurodegenerative disease (230)
Neuropsychiatric disorders (70)
Neuroscience (1953)
Neurotech (1)
NextGen: Class of 2026 (2035)
Non-profit (869)
Now hiring (30)
Obesity (329)
Opinion (125)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (301)
Patient recruitment (327)
Peanut (43)
People (26684)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15477)
Phase 2 (20289)
Phase 3 (12835)
Pipeline (3241)
Policy (90)
Postmarket research (854)
Preclinical (6536)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (647)
Real estate (1450)
Recruiting (12)
Regulatory (9902)
Reports (19)
Research institute (971)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (182)
Series B (135)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2006)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (333)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Last 7 days (345)
Last 30 days (1155)
Last 365 days (17824)
2026 (1656)
2025 (18123)
2024 (20564)
2023 (22429)
2022 (26833)
2021 (27813)
2020 (23365)
2019 (16243)
2018 (11747)
2017 (13752)
2016 (11847)
2015 (14358)
2014 (10397)
2013 (7494)
2012 (7541)
2011 (7621)
2010 (7433)
Location
Africa (154)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (6)
Asia (18262)
Australia (3111)
California (7098)
Canada (1836)
China (772)
Colorado (246)
Connecticut (253)
Delaware (236)
Europe (39183)
Florida (902)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (397)
India (35)
Indiana (160)
Iowa (8)
Japan (222)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (742)
Massachusetts (5578)
Michigan (110)
Minnesota (247)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1645)
New Mexico (13)
New York (1760)
North Carolina (825)
North Dakota (6)
Northern California (3478)
Ohio (177)
Oklahoma (11)
Oregon (25)
Pennsylvania (1276)
Puerto Rico (9)
Rhode Island (25)
South America (215)
South Carolina (9)
Southern California (2824)
Tennessee (40)
Texas (904)
United States (23356)
Utah (96)
Virginia (136)
Washington D.C. (37)
Washington State (593)
West Virginia (1)
Wisconsin (45)
281,823 Results for "gemini therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI
January 22, 2026
·
7 min read
Press Releases
Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development
January 8, 2026
·
5 min read
Press Releases
GE HealthCare and Mayo Clinic unveil GEMINI-RT: A bold research collaboration in radiation therapy and advanced cancer care
December 4, 2025
·
5 min read
Press Releases
Revelation Biosciences to Develop Gemini for Infection in Severe Burn Patients
April 30, 2025
·
6 min read
Press Releases
Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells
March 17, 2025
·
7 min read
Press Releases
Ouster Launches Cloud Portal for Ouster Gemini Digital Lidar Perception Platform
March 18, 2025
·
5 min read
Drug Development
Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity
Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity.
June 24, 2024
·
9 min read
Drug Development
Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini
Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini.
March 4, 2024
·
5 min read
Drug Development
Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)
AnaptysBio, Inc. announced positive top-line results from its global GEMINI-1 and GEMINI-2 Phase 3 trials evaluating the safety and efficacy of investigational imsidolimab in patients with generalized pustular psoriasis, a severe orphan disease that is potentially life-threatening if left untreated.
May 9, 2024
·
7 min read
Press Releases
Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND
December 3, 2024
·
5 min read
1 of 28,183
Next
